Trustees of Dartmouth College

The present disclosure relates to an array-based assay for transposase-accessible chromatin and prognostic molecular markers of treatment-resistant/early recurrent cancer. The present disclosure also relates to predicting an outcome, such as duration of disease-free survival, in a cancer patient.

In some embodiments, the present disclosure pertains to a bimetallic metal-organic framework. In some embodiments, the bimetallic metal-organic framework includes a plurality of first metals and a plurality of metal-containing ligands, where each metal-containing ligand includes a second metal and a ligand. In some embodiments, the ligand is coordinated with the second metal and at least one first metal. In some embodiments, the present disclosure pertains to a method of detecting an analyte in a sample by associating the sample with a bimetallic metal-organic framework, as disclosed herein, detecting a change in a property of the bimetallic metal-organic framework, and correlating the change in the property of the bimetallic metal-organic framework to the presence or absence of the analyte in the sample. In some embodiments, the present disclosure pertains to a method of making the bimetallic metal-organic frameworks disclosed herein.

An image sensor including one or more pixels is provided. At least one of the pixels can include a semiconductor substrate, a floating diffusion formed in the semiconductor substrate, a transfer gate configured to selectively cause transfer of photo-charges stored in the pixel to the floating diffusion, and a multigate source follower. The multigate source follower can include a channel, a source and a drain coupled by the channel, a modulation gate formed over the channel and coupled to the floating diffusion, and a first guard gate formed over the channel.

Disclosed is a system for evaluating brain trauma via regional changes in tissue impedance. The present disclosure describes a system for non-invasive intracranial monitoring, comprising two or more affecting electrodes arranged between a conductive location of a cranium of a patient and a location on a scalp of the patient, two or more effected electrodes arranged between the conductive location of the cranium of the patient and the location on the scalp of the patient, and processing circuitry configured to apply an electrical stimulus between the two or more affecting electrodes, measure an electrical stimulus differential between the two or more effected electrodes, calculate, for the two or more effected electrodes, a value of an impedance metric, and identify, based on the calculated value of the impedance metric, a health condition of the patient.

In an aspect, the present disclosure pertains to a method of making a material. Generally, the method includes one or more of the following steps of: (1) placing a mixture having one or more components in a container; and (2) extruding the mixture out of at least one opening of at least one nozzle. In an additional aspect, the present disclosure pertains to a material. In some embodiments, the material includes one or more components. In some embodiments, the one or more components are in the form of a multi-layered structure.

The invention provides a supramolecular polymer composition capable of co-assembly to maintain a three dimensional (3-D) macrostructural form after 3-D printing, made of a solvent, a template molecule; and a reactive component. The reactive component can be at least one monomer that is capable of hydrogen bonding with the template molecule to form a 1D supramolecular structure. The template may be an amphiphilic polymer. The monomer has at least two pendant groups capable of covalent crosslinking. The invention also includes a 3-D structure formed by crosslinking a 3-D printed supramolecular polymer composition, which optionally has a mesoporous structure. Also included is a method of manufacturing a 3-D structure by delivering a supramolecular polymer composition onto a surface of a substrate to form the 3-D structure.

Opioids can be detected using a test system with ZnO pillars arranged in an array on a silicon wafer. Silver particles are on a top surface and/or side surface of the ZnO pillars. A sample fluid is applied to the test system. A concentration of an opioid compound in the sample fluid is determined using Surface-Enhanced Raman Spectroscopy of the test system. The sample fluid can be blood or a fluid isolated from blood.

The present disclosure pertains to a molecule that is operable to release a nitroxyl (HNO) upon irradiation. The nitroxyl may be operable to convert to nitrous oxide (N 2 O). The present disclosure also pertains to methods of releasing nitroxyl from a molecule of the present disclosure by irradiating the molecule. The released nitroxyl may then convert to nitrous oxide. The present disclosure also pertains to methods of administering at least one of nitroxyl or nitrous oxide to a subject by (1) administering a molecule of the present disclosure to the subject; and (2) irradiating the molecule, where the irradiation results in the release of nitroxyl from the molecule. The released nitroxyl may then convert to nitrous oxide.

The present disclosure features methods for modifying fertility. In some embodiments, the disclosure provides contraceptive compositions and methods of using the same.

A methodology for non-metallic (anions; nitrogen, sulfur) electron donor incorporation in a MXene material by annealing of MXene in a furnace with a solid sulfur/nitrogen precursor compound (thiourea) under flowing pure nitrogen gas and hydrogen gas. MXenes are a family of layered 2D carbide materials based on a structure similar to M 3 C 2 T x where M is a metal such as titanium and T represents surface termination groups such as oxygen, fluorine, etc.